<DOC>
	<DOCNO>NCT00779350</DOCNO>
	<brief_summary>The purpose study evaluate relative bioavailability test formulation sertraline 100 mg tablet already market reference formulation Zoloft® 100 mg tablet ( Pfizer ) , fasted condition healthy male female adult subject .</brief_summary>
	<brief_title>Bioequivalence Study Sertraline Hydrochloride 100mg Tablets Under Fasting Conditions</brief_title>
	<detailed_description>This randomize , single-dose , two-way , crossover study conduct compare relative bioavailability two formulation 100 mg sertraline hydrochloride tablet fast condition . The study conduct 36 ( 30 complete ) healthy adult accordance protocol No . 10540323 ( Revision 0 ) . In study period , single 100 mg dose administer subject follow overnight fast least 10 hour . The test formulation Ranbaxy Research Laboratories 's Sertraline Hydrochloride 100 mg Tablets reference formulation ZOLOFT® ( sertraline hydrochloride ) 100 mg Tablets Manufactured Roerig ( Division Pfizer ) . The subject receive test product one study period reference product period ; order administration accord dose randomization schedule . There 14-day interval treatment . Blood sample collect pre-dose interval 144 hour dose . The plasma sample subject complete period study send Helen Fassoulas , B.Sc. , Director Operations , Warnex Bioanalytical Services Inc. , 3885 boul Industriel , Laval , Quebec , H7LAS3 Canada , Telephone : 450-663-6724 , ext . 438 , FAX : 450-975-8111 determination sertraline plasma concentration . Statistical analysis perform Yetta I. Wilbur , Biostatistician , Novum Pharmaceutical Research Services , 5900 Penn Avenue , Pittsburgh , PA 15206 , USA , Telephone : 412-363-3300 , Fax : 412-362-5783 evaluate relative bioavailability test formulation reference product . A total 36 healthy adult subject .</detailed_description>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Males female , 1865 year age ( inclusive ) . A body mass index ( BMI ) 1830 kg/m2 inclusive measure calculate accord Novum Standard Operating Procedures . Good health determine lack clinically significant abnormality health assessment perform screen . Signed date informed consent form , meet criteria current FDA regulation . Female subject child bear potential must either abstain sexual intercourse use reliable method contraception ( e.g . condom spermicide , IUD , hormonal contraceptive ) least 30 day prior dose duration study . If female , pregnant , lactate likely become pregnant study . History allergy sensitivity sertraline hydrochloride selective serotonin reuptake inhibitor 's ( SSRI 's ) , history drug hypersensitivity intolerance , opinion Investigator , would compromise safety subject study . Significant history current evidence chronic infectious disease , system disorder organ dysfunction . Presence gastrointestinal disease history malabsorption within last year . History psychiatric disorder occur within last two year require hospitalization medication . Presence medical condition require regular treatment prescription drug . Use pharmacologic agent know significantly induce inhibit drugmetabolizing enzyme within 30 day prior dose . Use within 14 day dose , anticipate use study , 14 day last dose sertraline monoamine oxidase inhibitor ( MAOIs ) . Receipt drug part research study within 30 day prior dose . Drug alcohol addiction require treatment past 12 month . Donation significant loss whole blood ( 480 ml ) with/n 30 day plasma within 14 day prior dose . Positive test result HIV , Hepatitis B surface antigen Hepatitis C antibody . Positive test result drug abuse screen . Positive serum pregnancy test .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Bioequivalence sertraline 100 mg tablet fast condition</keyword>
</DOC>